Quick Links

Author: Tina Taylor

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] The purpose of this study is to better understand why androgen deprivation therapy (ADT) increases risk of body weight gain, insulin resistance, and type 2 diabetes in men with prostate cancer. The specific question we are exploring is whether...

We are inviting you to participate in a research study focusing on blood sugar control in type 1 diabetes at UW Medicine Diabetes Institute. Our study aims to investigate the effects of blood sugar control on the structure and function of high-density lipoprotein (HDL), an...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] INTERESTED IN PARTICIPATING? Fill out our contact form: http://uwstudy.com/yard_ps?AD=ITHS Visit our website for more information: https://sites.uw.edu/uwyard/ ABOUT US The Young Adult Riding and Driving (YARD) Study is an ongoing research study about young adults’ transportation habits and health behaviors. We are housed...

Cannabis use disorder (CUD) is a significant and expanding health problem, and no FDA approved treatments are currently available. Persons with posttraumatic stress disorder (PTSD) may use cannabis to help control symptoms. Relief from PTSD insomnia, nightmares, anxiety, and preoccupying thoughts have been reported as...

To evaluate the efficacy of troriluzole as adjunctive therapy compared to placebo in subjects with OCD who have had an inadequate response to their current OCD treatment based on the change in their Y-BOCS score To assess the safety and tolerability of troriluzole, relative to placebo,...

To evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo, for the treatment of agitation in patients with dementia of the Alzheimer's type To evaluate the effects of AVP-786 compared to placebo on neuropsychiatric symptoms To evaluate the effects of AVP-786 compared to placebo on...

To evaluate the clinical efficacy of ATH-1017 To determine the safety and tolerability of ATH-1017 To evaluate the clinical efficacy of ATH-1017 separately on: (1) cognition and (2) clinical global impression of change To evaluate the effect of ATH-1017 on activities of daily living To determine the plasma pharmacokinetic (PK) profile...

To assess the effect of donanemab versus placebo on clinical progression in participants with early symptomatic AD with demonstrated presence of tau pathology To assess the effect of donanemab versus placebo on clinical progression of participants with early symptomatic AD To assess the effect of donanemab versus...

To determine if treatment with SAGE-217 reduces depressive symptoms in women with postpartum depression (PPD) compared to placebo. To determine if treatment with SAGE-217 reduces anxiety symptoms compared to placebo. To assess self-report of depressive symptoms To evaluate the safety and tolerability of SAGE-217 This is a PHASE 3...

SITE PARTNERS
uw-footer